Expression of IGFBP7 in acute leukemia is regulated by DNA methylation

Cancer Science

Volumn 102, Issue 1, 2011, Pages 253-259

  Heesch, Sandra ^a   Bartram, Isabelle ^a   Neumann, Martin ^a   Reins, Jana ^a   Mossner, Maximilian ^a   Schlee, Cornelia ^a   Stroux, Andrea ^a   Haferlach, Torsten ^b   Goekbuget, Nicola ^c   Hoelzer, Dieter ^c   Hofmann, Wolf Karsten ^d   Thiel, Eckhard ^a   Baldus, Claudia D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MLL MUNICH LEUKEMIA LABORATORY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF MANNHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CD133 ANTIGEN; CD34 ANTIGEN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; SOMATOMEDIN BINDING PROTEIN; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; PRIORITY JOURNAL; PYROSEQUENCING;

ADOLESCENT; ADULT; AGED; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; MIDDLE AGED; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RNA, MESSENGER;

EID: 78650199652     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01760.x     Document Type: Article

References (38)

1. Baldus CD, Tanner SM, Ruppert AS et al. BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. Blood 2003; 102: 1613-8.
2. Baldus CD, Martus P, Burmeister T et al. Low ERG and BAALC expression identifies a new subgroup of adult acute t-lymphoblastic leukemia with a highly favorable outcome. J Clin Oncol 2007; 25: 3739-45.
3. Langer C, Radmacher MD, Ruppert AS et al. High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. Blood 2008; 111: 5371-9.
4. Kuhnl A, Gokbuget N, Stroux A et al. High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia. Blood 2010; 115: 3737-44.
5. Heesch S, Schlee C, Neumann M et al. BAALC-associated gene expression profiles define IGFBP7 as a novel molecular target in acute leukemia. Leukemia 2010; 24: 1429-36.
6. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34.
7. Oh Y. IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth. Endocrine 1997; 7: 111-3.
8. Mutaguchi K, Yasumoto H, Mita K et al. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer. Cancer Res 2003; 63: 7717-23.
9. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008; 132: 363-74.
10. Sprenger CC, Vail ME, Evans K, Simurdak J, Plymate SR. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis. Oncogene 2002; 21: 140-7.
11. How HK, Yeoh A, Quah TC et al. Insulin-like growth factor binding proteins (IGFBPs) and IGFBP-related protein 1-levels in cerebrospinal fluid of children with acute lymphoblastic leukemia. J Clin Endocrinol Metab 1999; 84: 1283-7.
12. Vizioli MG, Sensi M, Miranda C et al. IGFBP7: an oncosuppressor gene in thyroid carcinogenesis. Oncogene 2010; 29: 3835-44.
13. Komatsu S, Okazaki Y, Tateno M et al. Methylation and downregulated expression of mac25/insulin-like growth factor binding protein-7 is associated with liver tumorigenesis in SV40T/t antigen transgenic mice, screened by restriction landmark genomic scanning for methylation (RLGS-M). Biochem Biophys Res Commun 2000; 267: 109-17.
14. Burger AM, Zhang X, Li H et al. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene 1998; 16: 2459-67.
15. Ruan W, Xu E, Xu F et al. IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis. Cancer Biol Ther 2007; 6: 354-9.
16. Wilson HM, Birnbaum RS, Poot M, Quinn LS, Swisshelm K. Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. Cell Growth Differ 2002; 13: 205-13.
17. Adachi Y, Itoh F, Yamamoto H et al. Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer. Int J Cancer 2001; 95: 216-22.
18. Chen Y, Pacyna-Gengelbach M, Ye F et al. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer. J Pathol 2007; 211: 431-8.
19. Lin J, Lai M, Huang Q et al. Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression. J Pathol 2007; 212: 83-90.
20. Ruan WJ, Lin J, Xu EP et al. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1. J Zhejiang Univ Sci B 2006; 7: 929-32.
21. Tost J, Gut IG. Analysis of gene-specific DNA methylation patterns by pyrosequencing technology. Methods Mol Biol 2007; 373: 89-102.
22. Gokbuget N, Raff R, Brugge-Mann M et al. Risk/MRD adapted GMALL trials in adult ALL. Ann Hematol 2004; 83(Suppl 1): S129-31.
23. Schwartz S, Rieder H, Schlager B et al. Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell pheno-type. Leukemia 2003; 17: 1589-95.
24. Heuser M, Beutel G, Krauter J et al. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood 2006; 108: 3898-905.
25. Heesch S, Goekbuget N, Stroux A et al. Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia. Haematologica 2010; 95: 942-9.
26. Mossner M, Hopfer O, Nowak D et al. Detection of differential mitotic cell age in bone marrow CD34(+) cells from patients with myelodysplastic syndrome and acute leukemia by analysis of an epigenetic molecular clock DNA signature. Exp Hematol 2010; doi:.
27. Haferlach T, Kohlmann A, Wieczorek L et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol 2010; 28: 2529-37.
28. Civin CI, Trischmann T, Kadan NS et al. Highly purified CD34-positive cells reconstitute hematopoiesis. J Clin Oncol 1996; 14: 2224-33.
29. Yin AH, Miraglia S, Zanjani ED et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-12.
30. Miraglia S, Godfrey W, Yin AH et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997; 90: 5013-21.
31. Carow CE, Levenstein M, Kaufmann SH et al. Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias. Blood 1996; 87: 1089-96.
32. Ferrando AA, Neuberg DS, Staunton J et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.
33. Ferrando AA, Look AT. Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol 2003; 40: 274-80.
34. Singal R, Ginder GD. DNA methylation. Blood 1999; 93: 4059-70.
35. Suzuki H, Igarashi S, Nojima M et al. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Carcinogenesis 2010; 31: 342-9.
36. Bergmann L, Miething C, Maurer U et al. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 1997; 90: 1217-25.
37. Gutierrez A, Sanda T, Ma W et al. Inactivation of LEF1 in T-cell acute lymphoblastic leukemia. Blood 2010; 115: 2845-51.
38. Coustan-Smith E, Mullighan CG, Onciu M et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 2009; 10: 147-56.